Frank Charles Papacostas MD

Located in Peabody MA you'll find the skilled healthcare provider known as Davekos Michael C Doctor Phys. Specializing in the field of medicine this professional offers a wealth of knowledge and experience to assist patients in their health journey. As a doctor Davekos Michael C Doctor Phys is dedicated to providing top-notch medical care to individuals in need. With a convenient location in Peabody MA patients can easily access the expertise and services offered by this esteemed healthcare provider. Generated from this place's public information

Located in the vibrant city of Salem MA you'll find Dr. Charles Joseph Leidner an esteemed M.D. specializing in General Allopathic Medicine. With a wealth of medical knowledge and experience Dr. Leidner is dedicated to providing top-notch care to his patients. As a Doctor of Medicine Dr. Leidner offers comprehensive medical services with a focus on general health and wellness. Patients can trust in his expertise and compassionate approach to healthcare making him a trusted provider in the Salem community. Generated from this place's public information

Ophthalmic Therapeutic Innovation, LLC is a leading biopharmaceutical company based in Peabody, MA. Led by Dr. Tina Guanting Qiu, a highly accomplished physician executive with extensive experience in global Pharma, biotech, and strategic consulting, the company specializes in the development of innovative therapies for ophthalmic diseases. With a unique approach that combines biology-based medicine and synthetic thinking, Ophthalmic Therapeutic Innovation aims to solve the most challenging problems in modern medicine development, achieving a remarkable success rate of 90%. Their core competences include retina and glaucoma specialty care, cornea and ocular surface diseases, as well as stem cell gene therapy and drug development. With a proven track record of success and expertise in clinical data analysis, Ophthalmic Therapeutic Innovation leverages big data evidence to create value for patients and shareholders. Driven by a visionary leader and guided by a commitment to precision and innovation, the company has made significant contributions to the field of ophthalmology, including the development of cutting-edge therapies such as Luxturna, the first FDA-approved human gene therapy for Leber congenital amaurosis. Through their groundbreaking research and strategic partnerships, Ophthalmic Therapeutic Innovation is revolutionizing the treatment of ophthalmic diseases and transforming modern medicine development.Generated from the website